- You can view the full GlaxoSmithKline Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
As the dust settles on Wednesday's contentious presidential debate, U.S. markets are actually teetering on the edge of breakout territory.
O'Shares Investment chairman and CNBC Shark Tank investor Kevin O'Leary says GlaxoSmithKline (GSK) has a huge advantage when selling to the U.S. market.
Britain's Brexit fortunes remain difficult to assess as markets offer mixed-signals on EU departure.
GlaxoSmithKline (GSK) appointed Brian McNamara CEO of its consumer healthcare division on Wednesday.